These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 22160039)

  • 1. Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fielding AK
    Hematology Am Soc Hematol Educ Program; 2011; 2011():231-7. PubMed ID: 22160039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
    Thomas X; Dombret H
    Leuk Lymphoma; 2008 Jul; 49(7):1246-54. PubMed ID: 18452076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful second allogeneic stem cell transplantation in second remission induced by dasatinib in a child with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Millot F; Cividin M; Brizard F; Chomel JC; Méchinaud F; Guilhot F
    Pediatr Blood Cancer; 2009 Jul; 52(7):891-2. PubMed ID: 19202569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance.
    Ottmann O
    Lancet Haematol; 2018 Dec; 5(12):e606-e607. PubMed ID: 30501865
    [No Abstract]   [Full Text] [Related]  

  • 5. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Outcome of autologous hematopoietic stem cell transplantation in combination with imatinib for 16 cases of Philadelphia chromosome positive acute lymphoblastic leukemia].
    Liu X; Jiang E; Huang Y; Yang D; Pang A; Wei J; Ma Q; Zhang R; Qiu L; Feng S; Han M
    Zhonghua Xue Ye Xue Za Zhi; 2014 Mar; 35(3):250-2. PubMed ID: 24666497
    [No Abstract]   [Full Text] [Related]  

  • 7. Philadelphia chromosome-positive Acute Lymphoblastic Leukemia.
    Forghieri F; Luppi M; Potenza L
    Hematology; 2015 Dec; 20(10):618-9. PubMed ID: 26574786
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment strategy for the patients with Philadelphia chromosome negative acute lymphoblastic leukemia in first remission].
    Takeuchi J
    Rinsho Ketsueki; 2010 Jul; 51(7):460-3. PubMed ID: 20693763
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Caocci G; Vacca A; Ledda A; Murgia F; Piras E; Greco M; Arras M; Atzeni S; Littera R; La Nasa G
    Biol Blood Marrow Transplant; 2012 Apr; 18(4):652-4. PubMed ID: 22240733
    [No Abstract]   [Full Text] [Related]  

  • 10. [Current treatment of philadelphia chromosome-positive acute lymphoblastic leukemia].
    Sugiura I
    Rinsho Ketsueki; 2014 Oct; 55(10):1972-80. PubMed ID: 25297762
    [No Abstract]   [Full Text] [Related]  

  • 11. BCR/ABL1 Kinase Domain Mutation Monitoring: Could Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Benefit As Well?
    Andolina JR
    Acta Haematol; 2015; 134(2):69-70. PubMed ID: 25895547
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
    Giebel S; Czyz A; Ottmann O; Baron F; Brissot E; Ciceri F; Cornelissen JJ; Esteve J; Gorin NC; Savani B; Schmid C; Mohty M; Nagler A
    Cancer; 2016 Oct; 122(19):2941-51. PubMed ID: 27309127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Additional Cytogenetic Abnormalities in Adults with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
    Aldoss I; Stiller T; Cao TM; Palmer JM; Thomas SH; Forman SJ; Pullarkat V
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1326-9. PubMed ID: 25842050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
    Steinberg M
    Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacies of hematopoietic stem cell transplantation plus imatinib in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a comparative study].
    Chen J; Wu DP; Chen F; Zhao Y; Sun AN; Qiu HY
    Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(8):583-7. PubMed ID: 23663336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Philadelphia-positive Acute Lymphoblastic Leukemia: Do We Still Need Allogeneic Transplantation? Argument "Pro".
    Bachanova V
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S10-S15. PubMed ID: 28760293
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of outcomes following autologous stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia during first complete remission.
    Kato H; Kawase T; Kako S; Mizuta S; Kurokawa M; Mori T; Ohashi K; Iwato K; Miyamura K; Hidaka M; Sakamaki H; Suzuki R; Morishima Y; Tanaka J;
    Haematologica; 2014 Nov; 99(11):e228-30. PubMed ID: 25015939
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment Selection for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors.
    Ma Y; Zhang Q; Kong P; Xiong J; Zhang X; Zhang C
    Chemotherapy; 2019; 64(2):81-93. PubMed ID: 31390613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of philadelphia chromosome-positive acute lymphoblastic leukemia.
    Chen H; Liu KY; Xu LP; Chen YH; Han W; Zhang XH; Wang Y; Qin YZ; Liu YR; Huang XJ
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1110-6. PubMed ID: 25698612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD?
    Aldoss I; Pullarkat V
    Bone Marrow Transplant; 2019 Jan; 54(1):3-5. PubMed ID: 30446742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.